Well I've been wrong on a couple of things.
I was wrong to suggest that the BLA resubmission had a 50% chance of success
But I was right that they would finally have to do another proper clinical trial for aGVHD, and that resubmitting the BLA wouldn't be a satisfactory milestone to unlock the additional Oaktree Loan.
I was right that Oaktree wouldn't extend the loan agreement.
I was right that Novartis was going to walk away from the collaboration for Covid ARDS research.
I was right that apart from the claimed success in the unsatisfactory single arm open label trial for aGVHD, every Mesoblast trial has failed to achieve the primary endpoint.
I was right that Mesoblast has effectively run out of funds, and will have difficulty finding another sucker.
- Forums
- ASX - By Stock
- banter and General Discussion
Well I've been wrong on a couple of things. I was wrong to...
-
- There are more pages in this discussion • 4,036 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.020(1.45%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.40 | $1.41 | $1.38 | $1.586M | 1.135M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 6902 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 9064 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7754 | 1.395 |
14 | 114520 | 1.390 |
14 | 132434 | 1.385 |
18 | 196290 | 1.380 |
11 | 156301 | 1.375 |
Price($) | Vol. | No. |
---|---|---|
1.400 | 9488 | 8 |
1.405 | 61692 | 10 |
1.410 | 154626 | 13 |
1.415 | 51407 | 8 |
1.420 | 129928 | 5 |
Last trade - 11.59am 17/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online